Amantadine, oseltamivir and zanamivir can be prescribed for influenza in patients who are considered to be at risk of severe illness and/or complications even if they are not in a 'clinical at-risk group'.
Antivirals can reduce the risk of death in patients hospitalised with influenza. A recent report from the Academy of Medical Sciences and the Wellcome Trust supports the routine use of antivirals when influenza circulates more widely or causes more severe symptoms.
All prescriptions for oseltamivir (Tamiflu) and zanamivir (Relenza) should be endorsed with the reference 'SLS' or pharmacies will be unable to supply them at NHS expense.
The DoH also highlights the importance of healthcare professionals, including GPs, getting vaccinated themselves to minimise the risk of flu transmission.